High sensitivity C-reactive protein (Hs-CRP) remains highly stable in long-term archived human serum
- 1 March 2014
- journal article
- Published by Elsevier in Clinical Biochemistry
- Vol. 47 (4-5) , 315-318
Abstract
No abstract availableKeywords
Funding Information
- Office of the Director
- National Institutes of Health (S06GM008016-320107, Z01HG200362)
- National Human Genome Research Institute
- National Institute of Diabetes and Digestive and Kidney Diseases
This publication has 17 references indexed in Scilit:
- Reproducibility of Metabolomic Profiles among Men and Women in 2 Large Cohort StudiesClinical Chemistry, 2013
- Variation of serum metabolites related to habitual diet: a targeted metabolomic approach in EPIC-PotsdamEuropean Journal of Clinical Nutrition, 2013
- Paradoxical Hyperadiponectinemia is Associated With the Metabolically Healthy Obese (MHO) Phenotype in African AmericansJournal of Endocrinology and Metabolism, 2012
- Meta-Analysis of Genome-Wide Association Studies in >80 000 Subjects Identifies Multiple Loci for C-Reactive Protein LevelsCirculation, 2011
- Performance evaluation of a multiplex assay for future use in biomarker discovery efforts to predict body compositionClinical Chemistry and Laboratory Medicine (CCLM), 2011
- Serum, plasma, and dried blood spot high-sensitivity C-reactive protein enzyme immunoassay for population researchJournal of Immunological Methods, 2010
- Comparison of soluble thrombomodulin, von Willebrand factor, tPA/PAI-1 complex, and high-sensitivity CRP concentrations in serum, EDTA plasma, citrated plasma, and acidified citrated plasma (Stabilyte™) stored at −70 °C for 8–11 yearsThrombosis Research, 2005
- High-sensitivity C-reactive protein, inflammation, and cardiovascular risk: from concept to clinical practice to clinical benefitAmerican Heart Journal, 2004
- Preanalytic and Analytic Sources of Variations in C-reactive Protein Measurement: Implications for Cardiovascular Disease Risk AssessmentClinical Chemistry, 2003
- Serum insulin‐like growth factor‐1 is not a useful marker of prostate cancerBJU International, 1999